Diagnostic uncertainty and epistemologic humility
Tóm tắt
Từ khóa
Tài liệu tham khảo
Perret D, Chang EY, Pang W, Shinada S, Panush RS (2013) Reflecting on pain management for patients with osteoarthritis and other rheumatic disorders: there’s more to pain management than managing pain. Pain Management 2(4):295–301
Bengson J, Moffett MA (2012) Knowing how: essays on knowledge, mind, and action. Oxford University Press
Arend WP, Firestein GS (2012) Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nature Rev Rheum 8:573–586. doi: 10.1038/nrrheum.2012.134
Dubois EL, Wallace DJ (1987) Dubois’ Lupus Erythematosus. Lea and Febiger, Philadelphia
Panush RS, Kramer N, Rosenstein ED (2016) Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes. Up-To-Date In Medicine. http://www.uptodate.com/contents/undifferentiated-systemic-rheumatic-connective-tissue-diseases-and-overlap-syndromes . Accessed 28 March 2017
Klemperer P (1961) The concept of collagen diseases in medicine. Amer Rev Respir Dis 83:331–339
Doria A, Mosca M, Gambari PF, Bombardieri S (2005) Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol 32:213–215
LeRoy EC, Maricq HR, Kahaleh MB (1980) Undifferentiated connective tissue syndromes. Arthritis Rheum 23:341–343
Kallenberg CG (1993) Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions. Curr Opin Rheumatol 5:809–815
Alarcon GS, Williams GV, Singer JZ, Steen VD, Clegg DO, Paulus HE, Billingsley LM, Luggen ME, Polisson RP, Wilkens RF et al (1991) Early undifferentiated connective tissue disease. I. Early clinical manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease. J Rheumatol 18:1332–1339
Clegg DO, Williams HJ, Singer JZ, Steen VD, Schlegel S, Ziminski C, Alarcon GS, Luggen ME, Polisson RP, Wilkens RF et al (1991) Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 18:1340–1343
Bulpitt KJ, Clements PJ, Lachenbruch PA, Paulus HE, Peter JB, Agopian MS, Singer JZ, Steen VD, Clegg DO, Ziminski CM, Alarcon GS, Luggen ME, Polisson RP, Wilkens RF, Reading JC, Williams HJ, Ward JR (1993) Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med 118:602–609
Alarcon GS, Willkens RF, Ward JR, Clegg DO, Morgan JG, Ma KN, Singer JZ, Steen VD, Paulus HE, Lugger ME, Polisson RP, Ziminski CM, Yarboro C, Williams HJ (1996) Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: follow-up analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline. Arthritis Rheum 39:403–414
Panush RS, Greer JM, Morshedian KK (1993) What is lupus? What is not lupus? Rheum Dis Clin N Am 19:223–234
Wolfe F, Ross K, Hawley DJ, Robertss FK, Cathey MA (1993) The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J Rheumatol 20:2005–2009
Panush RS, Hadler NM, Hellman DB, Leroy EC (1999) Yearbook of rheumatology, arthritis and musculoskeletal disease. In: Panush RS (ed) Health sciences, epidemiology, and economics (sex, sensationalism, greed, politics, law, and junk science: the story of the silicone breast implant controversy). Mosby-Yearbook, Missouri, pp 1–5
Angell M (1997) Science on trial: the class of medical evidence and the law in the breast implant case. WW Norton, New York
Kroenke K, Mangelsdorr AD (1989) Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med 86:262–266
Kanton W, Ries RK, Kleinman A (1984) The prevalence of somatization in primary care. Compr Psychiatry 25:208–215
Kanton WJ, Walker EA (1998) Medically unexplained symptoms in primary care. J Clin Psychiatry 59(Suppl 20):15–21
Kroenke K, Price RK (1993) Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Intern Med 153:2474–2480
Creed F, Barsky A (2004) A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 56:391–408
World Health Organization (1992) The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization. http://www.who.int/classifications/icd/en/bluebook.pdf Accessed on 28 Mar 2017
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, fourth edition, text revision. American Psychiatric Association, Washington DC
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). American Psychiatric Association, Arlington
Yutzy SH, Parish BS (2008) Somatoform disorders. In: The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th ed. American Psychiatric Publishing, Washington, DC
Goldenberg DL (1987) Fibromyalgia syndrome an emerging but controversial condition. JAMA 257:2782–2787
Bennett RM (2009) Clinical manifestations and diagnosis of fibromyalgia. Rheum Dis Clin N Am 35:215–232
Institute of Medicine (2015) Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. The National Academies Press; 2015 http://www.iom.edu/mecfs . Accessed on 28 March 2017
Mehta NR, Forgione AG, Rosenbaum RS, Holmberg R (1984) “TMJ” triad of dysfunctions: a biologic basis of diagnosis and treatment. J Mass Dent Soc 33:173–176
Cooper BC, Kleinberg I (2007) Examination of a large patient population for the presence of symptoms and signs of temporomandibular disorders. Cranio 25:114–126
Hartlage SA, Freels S, Gorman N, Yonkers K (2012) Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets. Arch Gen Psychiatry 69:300–305
Halbreich U, Backstrom T, Eriksson E et al (2007) Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol 23:123–130
Eis D, Helm D, Mühlinghaus T, Birkner N, Dietel A, Eikmann T, Gieler U, Herr C, Lacour M, Nowak D, Pedrosa Gil F, Podoll K, Renner B, Andreas Wiesmuller G, Worm M (2003) The German multicentre study on multiple chemical sensitivity (MCS). Int J Hyg Environ Health 211:658–681
Hausteiner C, Bornschein S, Bickel H et al (2003) Psychiatric morbidity and low self-attentiveness in patients with environmental illness. J Nerv Ment Dis 191:50–55
Das-Munshi J, Rubin GJ, Wessely S (2007) Multiple chemical sensitivities: review. Curr Opin Otolaryngol Head Neck Surg 15:274–280
Cahalan S (2012) Brain on fire: my month of madness. Penguin, NYC
Rate RG, Morse HG, Bonnell MD et al (1980) “Navajo arthritis” reconsidered: relationship to HLA-B27. Arthritis Rheum 23(11):1299–1302
Martin RW, Duffy J, Engel AG, Lie JT, Bowles CA, Moyer TP, Gleich GJ (1990) The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion: clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med 113(2):124–134
Kohn NN, Hughes RE, McCarty DJ Jr, Faires JS (1962) The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the “pseudogout syndrome”. II. Identification of crystals. Ann Intern Med 56:738–745
Johnson JA, Yu SS, Elist M, Arkfeld D, Panush RS (2015) Rheumatologic manifestations of the “MonoMAC” syndrome. A systematic review. Clin Rheumatol 34(9):1643–1645
Hadler NM, Greenhalgh S (2004) Labeling woefulness: the social construction of fibromyalgia. Spine 30:1–4
Hadler NM (2003) “Fibromyalgia” and the medicalization of misery. J Rheumatol 30:1668–1669